|
🐬
|
SOX7 regulates the expression of VE-cadherin in the haemogenic endothelium at the onset of haematopoietic development
Guilherme Costa,
Andrzej Mazan,
A. Gandillet,
S. Pearson,
G. Lacaud,
V. Kouskoff
|
6 |
2012 |
6
🐬
|
|
🐬
|
The Flk1‐Cre‐Mediated Deletion of ETV2 Defines Its Narrow Temporal Requirement During Embryonic Hematopoietic Development
Sarah Wareing,
Andrzej Mazan,
S. Pearson,
B. Göttgens,
G. Lacaud,
V. Kouskoff
|
5 |
2012 |
5
🐬
|
|
🐜
|
Effects of heme oxygenase-1 on induction and development of chemically induced squamous cell carcinoma in mice
18 auth.
H. Waś,
Malgorzata Sokolowska,
Aleksandra Sierpniowska,
P. Dominik,
K. Skrzypek,
B. Lackowska,
A. Prątnicki,
A. Grochot-Przęczek,
H. Taha,
J. Kotlinowski,
...
M. Kozakowska,
Andrzej Mazan,
W. Nowak,
L. Muchová,
L. Vítek,
A. Ratajska,
J. Dulak,
A. Józkowicz
|
5 |
2011 |
5
🐜
|
|
🐜
|
Endothelial precursor cell-based therapy to target the pathologic angiogenesis and compensate tumor hypoxia.
20 auth.
G. Collet,
K. Szade,
W. Nowak,
Krzysztof Klimkiewicz,
Bouchra El Hafny-Rahbi,
Karol Szczepanek,
D. Sugiyama,
K. Węglarczyk,
Alexandra Foucault-Collet,
A. Guichard,
...
Andrzej Mazan,
M. Nadim,
F. Fasani,
N. Lamerant‐Fayel,
C. Grillon,
S. Petoud,
J. Beloeil,
A. Józkowicz,
J. Dulak,
C. Kieda
|
4 |
2016 |
4
🐜
|
|
🐬
|
SOX7 expression is critically required in FLK1-expressing cells for vasculogenesis and angiogenesis during mouse embryonic development
A. Lilly,
Andrzej Mazan,
D. Scott,
G. Lacaud,
V. Kouskoff
|
4 |
2017 |
4
🐬
|
|
🐜
|
5-Keto-3-cyano-2,4-diaminothiophenes as selective maternal embryonic leucine zipper kinase inhibitors.
26 auth.
N. Boutard,
A. Sabiniarz,
Klaudia Czerwińska,
M. Jarosz,
A. Cierpich,
E. Kolasińska,
K. Wiklik,
Karolina Gluza,
Claude Commandeur,
A. Buda,
Agata Stasiowska,
A. Bobowska,
Mariusz Galek,
C. Fabritius,
M. Bugaj,
...
Edyta Palacz,
Andrzej Mazan,
A. Zarebski,
K. Krawczyńska,
M. Żurawska,
Przemysław Zawadzki,
M. Milik,
Paulina Węgrzyn,
Monika Dobrzańska,
K. Brzózka,
P. Kowalczyk
|
2 |
2019 |
2
🐜
|
|
🐜
|
Abstract B48: Identification of potent, cell active MTH1 inhibitors and their use in target validation studies
17 auth.
Elisabetta Leo,
A. Petrocchi,
Jennifer P Bardenhagen,
M. Alimova,
Xi Shi,
C. Parker,
Naphtali J. Reyna,
M. Hamilton,
E. Felix,
Andrzej Mazan,
...
C. Dillon,
F. Mseeh,
J. Marszalek,
C. Toniatti,
G. Draetta,
Phil Jones,
Richard T. Lewis
|
0 |
2015 |
0
🐜
|
